Ranked on: #10 Top VC Firms in Boston 2026 (Ranked by Deals) · #108 Most Active Growth Investors of 2026 (Ranked) · Get your badge →
Is this your firm? Get featured or correct your listing →
Strategy
Stages
Pre-SeedSeedSeries A
Sectors
Technology
Geographies
USABoston, Massachusetts, USA
Check size
$100K - $5MRecent changes
- Jun 30, 2026Jun 30, 2026Invested in Flare Therapeutics (Series C, $85M) GlobeNewswire
- Jun 3, 2026Jun 3, 2026New fund: Third Rock Ventures Fund VII (target $750M) SEC EDGAR Form D
Funds
1| Fund | Vintage | Size | Strategy | Source |
|---|---|---|---|---|
| Third Rock Ventures Fund VII | 2026 | target $750M | Flagship | As of Jun 3, 2026SEC EDGAR Form D |
Portfolio
1 totalRecent Investment Activity
1Track record: led 1 and participated in 0 of 1 tracked venture round · 1 in the last 12 months · led 1 Series C
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Flare Therapeutics | Series C | Led | $85M | — | Pulse story |
Co-Investors
8Similar Firms
overlapping sector, stage or regionLatest Pulse
- Jul 2, 2026Crunchbase: The Week's 10 Biggest Funding Rounds, Led by Joulent's $1.75B Energy RaiseCrunchbase News' roundup of the week's 10 biggest funding rounds (June 27-July 2) was led by Houston-based energy infrastructure provider Joulent's $1.75 billion raise from National Grid Ventures, aimed squarely at AI and compute-intensive industries' power needs. Together AI's $800M Series C and Venice AI's $65M unicorn round both placed inside the top 10, alongside biotech, legal-tech, sports and video-AI rounds spanning a genuinely broad set of categories beyond pure frontier-model AI.→
- Jun 30, 2026Flare Therapeutics Raises $85M, Names New CEOFlare Therapeutics closed an $85 million insider-led Series C and named Anna Protopapas CEO, funding its first-in-class ARON-targeting degrader for prostate cancer toward a Phase 1A trial expected in Q3 2026.→
Third Rock Ventures FAQ
What companies has Third Rock Ventures invested in?
Third Rock Ventures' portfolio includes Flare Therapeutics.
Who does Third Rock Ventures co-invest with most?
In the rounds Value Add tracks, Third Rock Ventures most often invests alongside Boxer Capital (1 shared deal), Casdin Capital (1 shared deal), Eli Lilly (1 shared deal), Eli Lilly and Company (1 shared deal), GordonMD Global Investments (1 shared deal).
Sources & methodologyshow
Where these figures come from
- GlobeNewswireprimary source1 fact
- SEC EDGAR Form Dprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.